Filing metadata

Accession number
0001104659-25-041340
Form type
Form 3
Filer
ArriVent BioPharma, Inc.
CIK
CIK 1868279
Filed
Apr 29, 2025
Reporting period
Apr 28, 2025
Description
Initial ownership

Explore SEC Filings Hub